Tarantino Ilaria, Barresi Luca, Petridis Ioannis, Volpes Riccardo, Traina Mario, Gridelli Bruno
ISMETT/UPMC, via tricomi 1, Palermo 90100, Italy.
World J Gastroenterol. 2008 Jul 14;14(26):4185-9. doi: 10.3748/wjg.14.4185.
To evaluate the efficacy of endoscopic treatment in patients who undergo OLTx or LRLTx and develop biliary complications.
This is a prospective, observational study of patients who developed biliary complications, after OLTx and LRLTx, with duct-to-duct anastomosis performed between June 2003 and June 2007. Endoscopic Retrograde Cholangiopancreatography (ERCP) was considered unsuccessful when there was evidence of continuous bile leakage despite endoscopic stent placement, or persistence of stenosis after 1 year, despite multiple dilatation and stent placement. When the ERCP failed, a percutaneous trans-hepatic approach (PTC) or surgery was adopted.
From June 2003 to June 2007, 261 adult patients were transplanted in our institute, 68 from living donors and 193 from cadaveric donors. In the OLTx group the rate of complications was 37.3%, while in the LRLTx group was 64.7%. The rate of ERCP failure was 19.4% in the OLTx group and 38.6% in LRLTx group. In OLTx group, 1 patient was re-transplanted and 8 patients died. In the LRLTx group, 2 patients underwent OLTx and 8 patients died. The follow-up was 23.3 +/- 13.13 mo and 21.02 +/- 14.10 mo, respectively.
Although ERCP is quite an effective mode of managing post-transplant bile duct complications, a significant number of patients need other types of approach. Further prospective studies are necessary in order to establish whether other endoscopic protocols or new devices, could improve the current results.
评估内镜治疗在接受原位肝移植(OLTx)或活体肝移植(LRLTx)并发生胆道并发症患者中的疗效。
这是一项对2003年6月至2007年6月期间接受OLTx和LRLTx且采用胆管对胆管吻合术并发生胆道并发症患者的前瞻性观察研究。当尽管放置了内镜支架仍有持续胆汁漏的证据,或尽管多次扩张和放置支架但1年后仍存在狭窄时,内镜逆行胰胆管造影(ERCP)被视为失败。当ERCP失败时,采用经皮经肝途径(PTC)或手术。
2003年6月至2007年6月,我院共对261例成年患者进行了移植,其中68例来自活体供体,193例来自尸体供体。OLTx组并发症发生率为37.3%,而LRLTx组为64.7%。OLTx组ERCP失败率为19.4%,LRLTx组为38.6%。OLTx组有1例患者再次移植,8例患者死亡。LRLTx组有2例患者接受了OLTx,8例患者死亡。随访时间分别为23.3±13.13个月和21.02±14.10个月。
尽管ERCP是处理移植后胆管并发症的一种相当有效的方式,但仍有相当数量的患者需要其他类型的治疗方法。有必要进行进一步的前瞻性研究,以确定其他内镜方案或新设备是否能改善当前的治疗效果。